[Correlation between fibrinolysis and the indexes of blood coagulation and of hepatic damage in chronic liver disease and liver cirrhosis].
作者信息
Craveri A, Cerrini R, Repaci G, Saracino F
出版信息
G Clin Med. 1968 Dec;49(12):1326-53.
PMID:4242987
Abstract
摘要
相似文献
1
2
[Changes of plasma fibrinolytic activity in chronic disorders of the liver and biliary tract].[慢性肝脏和胆道疾病时血浆纤溶活性的变化]
Sb Lek. 1971 Apr;73(4):89-98.
3
[Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
Orv Hetil. 1994 Dec 18;135(51):2821-4.
4
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.四种检测不同疾病患者纤维蛋白原降解产物方法的比较研究。
N Engl J Med. 1970 Sep 24;283(13):663-8. doi: 10.1056/NEJM197009242831301.
5
Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
Thromb Haemost. 2001 Apr;85(4):667-70.
6
[Studies of fibrinolytic activity and disseminated intravascular coagulation in chronic hepatitis and liver cirrhosis].[慢性肝炎和肝硬化中纤溶活性及弥散性血管内凝血的研究]
Rev Med Chir Soc Med Nat Iasi. 1972 Apr-Jun;76(2):311-8.
7
Hyperfibrinolysis in cirrhosis.
Am J Gastroenterol. 1973 Sep;60(3):280-9.
8
[Fibrinolysis as a cause of coagulopathy in patients with chronic diffuse diseases of the liver].
Klin Med (Mosk). 1991 Apr;69(4):73-5.
9
Assessment of coagulation and fibrinolysis in children with chronic liver disease.慢性肝病患儿凝血与纤溶功能的评估
Blood Coagul Fibrinolysis. 2013 Mar;24(2):113-7. doi: 10.1097/MBC.0b013e3283569297.
10
Hemostasis and global fibrinolytic capacity in chronic liver disease.慢性肝病中的止血与整体纤维蛋白溶解能力
Blood Coagul Fibrinolysis. 2007 Oct;18(7):623-6. doi: 10.1097/MBC.0b013e328285d80e.
Zotero 插件